Wael Abdel-Razek

April 18, 2023
Impacts of the Egyptian National Screening and Treatment Programme for Viral Hepatitis C: A Cost-Effectiveness Model
Summary Egypt used to have one of the highest prevalences of HCV infection worldwide. The Egyptian Ministry of Health launched a national campaign for the detection and management of HCV to reduce its burden. This study aims to carry out a cost-effectiveness analysis to evaluate the costs and benefits of the Egyptian national screening and […]

Read More
July 22, 2015
Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies
Summary Background The prevalence of hepatitis C virus (HCV) infection in Egypt is the highest in the world, yet the total economic burden has not been quantified. Improved understanding of costs and the impact of treatment strategies will provide for better allocation of resources to reduce HCV disease and economic burden. Aim A modelling approach […]

Read More

English